The differential gene expression analysis between TNBC, HER2+ or ER/PR+ samples identified MLK4 among the top 1% of all genes with the highest probability of being differentially expressed between TNBC and other breast cancer subtypes (Supplementary Fig. 1b-d). Here, MAP3K21 is linked to breast carcinoma.